Christopher M. Booth, MD

Profile

Dr. Booth is a Medical Oncologist and Assistant Professor in the Department of Oncology at Queen's University. Dr. Booth is building a program of health services and outcomes research specifically related to the use of systemic therapy for cancer. He has received funding to develop a chemotherapy database which would include chemotherapy data from all provincial cancer centres, supplemented by billing data from the provincial health insurance plan, which is going to be linked to the CCE existing data-base to permit population-based studies of the use of chemotherapy, similar to those that we have done previously with radiotherapy.  Construction of the data base will be initiated in the forthcoming year.  Other initiatives moving forward include population-based studies of adjuvant chemotherapy for non-small cell lung cancer (funded by CIHR) and bladder cancer (funded by CCO).  Specific objectives are to evaluate the effectiveness of new therapies in the general population, assess adherence to treatment guidelines, and to explore issues of access to, and quality of, cancer care in medical oncology.  Having completed a 2-year research fellowship at NCIC-Clinical Trials Group, Dr. Booth also has interest in the design, implementation, and interpretation of randomized clinical trials.

Current Interests

• Uptake and outcomes of novel anti-cancer therapies in Ontario, specifically related to bladder cancer, non-small cell lung cancer and colorectal cancer.
• Methodology and interpretation of randomized clinical trials (RCTs) in medical oncology.

Publications

Dr. Booth's publications are available on PubMed.